| European Case Law Identifier: | ECLI:EP:BA:2014:T087912.20140827 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 27 August 2014 | ||||||||
| Case number: | T 0879/12 | ||||||||
| Application number: | 07022045.4 | ||||||||
| IPC class: | C12N 15/28 C07K 14/525 C12N 15/62 C12N 15/86 C12N 5/10 A61K 38/19 C07K 16/24 C12N 5/18 A01K 67/027 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | APO-2 ligand | ||||||||
| Applicant name: | Genentech, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.08 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Double patenting (no) - scope of swiss type claim and scope of Article 54(5) EPC2000 claim not the same Remittal to the department of first instance - (yes) |
||||||||
| Catchwords: |
see points 10 to 16 of the Reasons |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t120879eu1.html
Date retrieved: 17 May 2021
16 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
Offical Journal of the EPO
XOJ EPO 2020, A104 - Interlocutory Decision of Technical Board of Appeal 3.3.01 dated 7 February 2019 - T 318/14